EIF4G2 and triple-negative breast carcinoma: Moreover, EIF4G2 protein levels were elevated in metastatic tumors compared to non-metastatic tumors from a very small cohort of triple negative breast cancer patients, and high mRNA levels correlated with poor metastasis-free survival rates [21].